英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Angell查看　Angell　在百度字典中的解释百度英翻中〔查看〕
Angell查看　Angell　在Google字典中的解释Google英翻中〔查看〕
Angell查看　Angell　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • DUPIXENT. DUPIXENT - Food and Drug Administration
    1-844-387-4936 or FDA at 1-800-FDA-1088 or DUPIXENT 200 mg injections at different injection sites Administer subcutaneous injection into the thigh or abdomen, except for the 2 inches (5 cm) around the navel The upper arm can also be used if a caregiver administers the injection
  • Dupixent (dupilumab) FDA Approval History - Drugs. com
    Approval Dupixent (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE) Jan 16, 2024 Approval Dupixent (dupilumab) U S Label Updated with Data Further Supporting Use in Atopic Dermatitis with Moderate-to-Severe Hand and Foot Involvement
  • Search | FDA - U. S. Food and Drug Administration
    Dupixent is FDA-approved for multiple indications, including … with nasal polyposis, and eosinophilic esophagitis Dupixent comes as a single-dose pre-filled syringe with …
  • Take Action With DUPIXENT® (dupilumab)
    Learn more about DUPIXENT® (dupilumab), a prescription medicine FDA-approved to treat eight conditions See how DUPIXENT® may help Serious side effects can occur Please see Important Safety Information and Prescribing Information and Patient Information on website
  • FDA Approves Dupixent as First Targeted Treatment for Bullous . . .
    Today, the FDA approved Dupixent (dupilumab) as the first and only targeted therapy for adult patients with bullous pemphigoid (BP), a rare, chronic and painful inflammatory skin disease This approval marks the eighth disease indication for Dupixent as a new alternative for patients—many of whom are elderly and have limited treatment options
  • Regeneron and Sanofi Announce FDA Approval of Dupixent for . . . - Nasdaq
    Dupixent was previously granted Orphan Drug Designation by the FDA for BP, which applies to investigational medicines intended for the treatment of rare diseases that affect fewer than 200,000
  • label - Food and Drug Administration
    label - Food and Drug Administration
  • Dupixent FDA approved as first and only treatment indicated for . . .
    The FDA evaluated Dupixent for this expanded indication under Priority Review, which is reserved for medicines that represent potentially significant improvements in efficacy or safety in treating serious conditions EoE is a chronic, progressive disease driven in part by type 2 inflammation that damages the
  • FDA approves new eczema drug Dupixent
    The FDA granted the approval of Dupixent to Regeneron Pharmaceuticals, Inc The FDA, an agency within the U S Department of Health and Human Services, protects the public health by assuring the
  • FDA approves Dupixent for bullous pemphigoid - Healio
    The FDA approved Dupixent for the treatment of adults with bullous pemphigoid, a rare skin disease often uncontrolled with systemic corticosteroids, Sanofi and Regeneron announced The FDA’s





中文字典-英文字典  2005-2009